2 Minute Medicine

No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia

MATCHPOINT trial

byKathleen Lau

in StudyGraphics

Reading Time: 1 min read

RELATED REPORTS

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

Zorevunersen appears safe and may alleviate symptoms in children with Dravet syndrome

Tags: allogeneic haematopoietic stem-cell transplantation (HSCT)allogeneic hematopoietic cell transplantation blast-phase chronic myeloid leukaemia blast-phase chronic myeloid leukemia blood cancer chemo chemotherapy chronic myeloid leukaemia chronic myeloid leukemia CML cytarabine dose limiting toxicity filgrastim flag-ida fludarabine granulocyte colony-stimulating factor (G-CSF)grastofil haematology hematology heme high risk population HSCT idarubicin lapelga leukaemia leukemia onc oncology pegfilgrastim phase 1 trial phase 2 trial ponatinib stem cell transplant survival tolerability toxicity transplant tyrosine kinase inhibitor

#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication

2 Minute Medicine Rewind June 13, 2022

RelatedReports

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

Thoracic radiotherapy improves survival in small-cell lung cancer patients

Chronic Disease

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

Neurology

Zorevunersen appears safe and may alleviate symptoms in children with Dravet syndrome

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

Next Post

Long-term outcomes for off-pump and on-pump CABG are similar

2 Minute Medicine Rewind June 13, 2022

Multiple variables related to physical activity levels in preschool children

Blended physical literacy interventions may improve physical literacy in children

Patient Basics: Anal Disorders

Neoadjuvant dostarlimab is a promising treatment option in locally advanced dMMR rectal cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.